Oxindole alkaloids from Uncaria tomentosa induce apoptosis in proliferating, G0/G1-arrested and bcl-2-expressing acute lymphoblastic leukaemia cells

被引:73
作者
Bacher, N
Tiefenthaler, M
Sturm, S
Stuppner, H
Ausserlechner, MJ
Kofler, R
Konwalinka, G
机构
[1] Univ Innsbruck, Dept Internal Med, A-6020 Innsbruck, Austria
[2] Austrian Acad Sci, Tyrolean Canc Res Inst, A-1010 Vienna, Austria
[3] Austrian Acad Sci, Inst Biomed Aging Res, Cell Metab & Differentiat Res Grp, A-1010 Vienna, Austria
[4] Univ Innsbruck, Dept Nephrol, A-6020 Innsbruck, Austria
[5] Univ Innsbruck, Fac Chem & Pharm, Dept Pharm, A-6020 Innsbruck, Austria
[6] Univ Innsbruck, Bioctr, Div Mol Pathophysiol, A-6020 Innsbruck, Austria
[7] Univ Innsbruck, Dept Paediat, Mol Biol Res Lab, A-6020 Innsbruck, Austria
关键词
Uncaria tomentosa; alkaloids; apoptosis; lymphoblastic leukaemia; cell-cycle arrest;
D O I
10.1111/j.1365-2141.2005.05907.x
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Natural products are still an untapped source of promising lead compounds for the generation of antineoplastic drugs. Here, we investigated for the first time the antiproliferative and apoptotic effects of highly purified oxindole alkaloids, namely isopteropodine (A1), pteropodine (A2), isomitraphylline (A3), uncarine F (A4) and mitraphylline (A5) obtained from Uncaria tomentosa, a South American Rubiaceae, on human lymphoblastic leukaemia T cells (CCRF-CEM-C7H2). Four of the five tested alkaloids inhibited proliferation of acute lymphoblastic leukaemia cells. Furthermore, the antiproliferative effect of the most potent alkaloids pteropodine (A2) and uncarine F (A4) correlated with induction of apoptosis. After 48 h, 100 mu mol/l A2 or A4 increased apoptotic cells by 57%. CEM-C7H2 sublines with tetracycline-regulated expression of bcl-2, p16ink4A or constitutively expressing the cowpox virus protein crm-A were used for further studies of the apoptosis-inducing properties of these alkaloids. Neither overexpression of bcl-2 or crm-A nor cell-cycle arrest in G0/G1 phase by tetracycline-regulated expression of p16INK4A could prevent alkaloid-induced apoptosis. Our results show the strong apoptotic effects of pteropodine and uncarine F on acute leukaemic lymphoblasts and recommend the alkaloids for further studies in xenograft models.
引用
收藏
页码:615 / 622
页数:8
相关论文
共 27 条
[1]   Anti-inflammatory activity of two different extracts of Uncaria tomentosa (Rubiaceae) [J].
Aguilar, JL ;
Rojas, P ;
Marcelo, A ;
Plaza, A ;
Bauer, R ;
Reininger, E ;
Klaas, CA ;
Merfort, I .
JOURNAL OF ETHNOPHARMACOLOGY, 2002, 81 (02) :271-276
[2]   The cell cycle inhibitor p16INK4A sensitizes lymphoblastic leukemia cells to apoptosis by physiologic glucocorticoid levels [J].
Ausserlechner, MJ ;
Obexer, P ;
Wiegers, GJ ;
Hartmann, BL ;
Geley, S ;
Kofler, R .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2001, 276 (14) :10984-10989
[3]   Cell cycle perturbations in acute myeloid leukemia samples following in vitro exposures to therapeutic agents [J].
Banker, DE ;
Groudine, M ;
Willman, CL ;
Norwood, T ;
Appelbaum, FR .
LEUKEMIA RESEARCH, 1998, 22 (03) :221-239
[4]  
Carroll William L, 2003, Hematology Am Soc Hematol Educ Program, P102
[5]  
CARSON DA, 1983, BLOOD, V62, P737
[6]   The role of the Bcl-2 protein family in cancer [J].
Coultas, L ;
Strasser, A .
SEMINARS IN CANCER BIOLOGY, 2003, 13 (02) :115-123
[7]   Involvement of the CD95 (APO-1/Fas) receptor/ligand system in drug-induced apoptosis in leukemia cells [J].
Friesen, C ;
Herr, I ;
Krammer, PH ;
Debatin, KM .
NATURE MEDICINE, 1996, 2 (05) :574-577
[8]   The interleukin 1 beta-converting enzyme inhibitor CrmA prevents Apo1/Fas- but not glucocorticoid-induced poly(ADP-ribose) polymerase cleavage and apoptosis in lymphoblastic leukemia cells [J].
Geley, S ;
Hartmann, BL ;
Kapelari, K ;
Egle, A ;
Villunger, A ;
Heidacher, D ;
Greil, R ;
Auer, B ;
Kofler, R .
FEBS LETTERS, 1997, 402 (01) :36-40
[9]   Bcl-2 interferes with the execution phase, but not upstream events, in glucocorticoid-induced leukemia apoptosis [J].
Hartmann, BL ;
Geley, S ;
Löffler, M ;
Hattmannstorfer, R ;
Strasser-Wozak, EMC ;
Auer, B ;
Kofler, R .
ONCOGENE, 1999, 18 (03) :713-719
[10]  
Kawakami Y, 2001, ANTICANCER RES, V21, P2537